vs

Side-by-side financial comparison of Forafric Global PLC (AFRI) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $159.7M, roughly 1.4× Forafric Global PLC). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -7.5%, a 26.9% gap on every dollar of revenue. Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $146.0K).

Forafric Global PLC is an Africa-focused agribusiness operating across the full agricultural value chain, covering staple food production, processing, and distribution. Its core markets are North and West Africa, supplying grain, vegetable oil and essential food commodities to consumer, retail and industrial clients.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

AFRI vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.4× larger
ORGO
$225.6M
$159.7M
AFRI
Higher net margin
ORGO
ORGO
26.9% more per $
ORGO
19.4%
-7.5%
AFRI
More free cash flow
ORGO
ORGO
$34.6M more FCF
ORGO
$34.8M
$146.0K
AFRI

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
AFRI
AFRI
ORGO
ORGO
Revenue
$159.7M
$225.6M
Net Profit
$-12.0M
$43.7M
Gross Margin
10.7%
Operating Margin
-2.5%
28.1%
Net Margin
-7.5%
19.4%
Revenue YoY
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AFRI
AFRI
ORGO
ORGO
Q4 25
$225.6M
Q3 25
$150.9M
Q2 25
$159.7M
$101.0M
Q1 25
$86.7M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$145.6M
$130.2M
Q1 24
$110.0M
Net Profit
AFRI
AFRI
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$21.6M
Q2 25
$-12.0M
$-9.4M
Q1 25
$-18.8M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$-8.6M
$-17.0M
Q1 24
$-2.1M
Gross Margin
AFRI
AFRI
ORGO
ORGO
Q4 25
Q3 25
Q2 25
10.7%
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
9.4%
77.6%
Q1 24
73.9%
Operating Margin
AFRI
AFRI
ORGO
ORGO
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-2.5%
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-0.9%
-10.7%
Q1 24
-3.5%
Net Margin
AFRI
AFRI
ORGO
ORGO
Q4 25
19.4%
Q3 25
14.3%
Q2 25
-7.5%
-9.3%
Q1 25
-21.7%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
-5.9%
-13.1%
Q1 24
-1.9%
EPS (diluted)
AFRI
AFRI
ORGO
ORGO
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AFRI
AFRI
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$12.2M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3M
$300.1M
Total Assets
$246.1M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AFRI
AFRI
ORGO
ORGO
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$12.2M
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$16.4M
$89.9M
Q1 24
$88.6M
Total Debt
AFRI
AFRI
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$18.4M
$63.8M
Q1 24
$65.2M
Stockholders' Equity
AFRI
AFRI
ORGO
ORGO
Q4 25
$300.1M
Q3 25
$255.1M
Q2 25
$5.3M
$233.2M
Q1 25
$242.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$16.3M
$263.5M
Q1 24
$278.0M
Total Assets
AFRI
AFRI
ORGO
ORGO
Q4 25
$598.7M
Q3 25
$509.8M
Q2 25
$246.1M
$461.1M
Q1 25
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$287.1M
$443.2M
Q1 24
$458.5M
Debt / Equity
AFRI
AFRI
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
1.13×
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AFRI
AFRI
ORGO
ORGO
Operating Cash FlowLast quarter
$706.0K
$39.4M
Free Cash FlowOCF − Capex
$146.0K
$34.8M
FCF MarginFCF / Revenue
0.1%
15.4%
Capex IntensityCapex / Revenue
0.4%
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AFRI
AFRI
ORGO
ORGO
Q4 25
$39.4M
Q3 25
$3.1M
Q2 25
$706.0K
$-32.9M
Q1 25
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$10.5M
$4.7M
Q1 24
$-10.2M
Free Cash Flow
AFRI
AFRI
ORGO
ORGO
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$146.0K
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$6.4M
$2.9M
Q1 24
$-12.4M
FCF Margin
AFRI
AFRI
ORGO
ORGO
Q4 25
15.4%
Q3 25
0.6%
Q2 25
0.1%
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
4.4%
2.2%
Q1 24
-11.3%
Capex Intensity
AFRI
AFRI
ORGO
ORGO
Q4 25
2.1%
Q3 25
1.5%
Q2 25
0.4%
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
2.8%
1.4%
Q1 24
2.0%
Cash Conversion
AFRI
AFRI
ORGO
ORGO
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AFRI
AFRI

Sales to external customers, Total$159.7M100%
Couscous & Pasta$934.0K1%
Soft Wheat$393.0K0%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons